Product
Supplier
Encyclopedia
Inquiry
Home > Biochemical Engineering > Polypeptide > KLOW80 for Sale > Retatrutide 99% API raw material klow80 hair growth peptides
Retatrutide 99% API raw material klow80 hair growth peptides buy - large image1
Retatrutide 99% API raw material klow80 hair growth peptides buy - image1
Retatrutide 99% API raw material klow80 hair growth peptides buy - image2
Retatrutide 99% API raw material klow80 hair growth peptides buy - image3
Retatrutide 99% API raw material klow80 hair growth peptides buy - image4
Retatrutide 99% API raw material klow80 hair growth peptides buy - image5
Retatrutide 99% API raw material klow80 hair growth peptides buy - image6

Retatrutide 99% API raw material klow80 hair growth peptides

TDS 4 Inquiries

Unit Price:

$10-11/G FOB

Get Latest Price
CAS No.:

654724-35-3

Grade:

Pharmaceutical Grade

Content:

99%

Port:

Shenzhen

Brand:

No Brand

Packaging:

5mg 10mg 15mg 20mg 30mg 40mg 60mg 1g

Price valid (until):

2026-10-08

Company Type:
Trader
Location:
China
Qualification:
Main Products:

Peptides,Tirzepatide,Retatrutide,GLP-1,Semaglutide,AMK-CU

  • Product Description

  • Seller Information

  • Inquiry History

  • Description

     whatsapp:+852 5608 7991                                  Shop Retatrutide Lyophilized Powder Manufacturer Supply RT10 RT20 RT30 RT40-Detailed Image 1





             

        Retatrutide is a triple glucagon, GIP, and receptor agonist. Retatrutide showed glucose control and weight loss in patients with type 2 diabetes mellitus (T2DM).Retatrutide (LY3437943) is a triple agonist peptide of the glucagon receptor (GCGR), glucosedependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor .Retatrutide can be used for the research of obesity.Normally, this peptide will be delivered in lyophilized form and should be stored in a freezer at or below -20 °C.      

     

    Product Name Retatrutide Powder
    Name Retatrutide
    Type Lyophilized Powder
    storage Store in a cool and dark place
    CAS No 2381089-83-2
    Purity >99%
    Specific 5mg 10mg 15mg 20mg 30mg 40mg 60mg 1g
    Package 10 vials/box/kit
    Shop Retatrutide Lyophilized Powder Manufacturer Supply RT10 RT20 RT30 RT40-Detailed Image 2
    Shop Retatrutide Lyophilized Powder Manufacturer Supply RT10 RT20 RT30 RT40-Detailed Image 3

    FAQ

    Q1: May I buy one vial as a try?

    Re: Yes, it is ok.


    Q2: Which payment is available for your company?

    Re: T/T, PayPal,bank transfer etc. You can choose the one which is convenient for you.


    Q3: What's the lead time and shipping ways?

    Re: Generally, the goods will be delivered to you by international courier(DHL, UPS, FedEx etc.) or by air. Usually it would take about 8-10 days to your shipping address.

    Company Profile:

    PLANOVO BIOTECH CO LTD is a biotechnology innovation company determined to serve the world. It is located in the Hangzhou city, and specialized in the research and development of peptide and specialty chemicals and GMP production, and have accumulated profound professional knowledge and practical skills in the industry.Shop Retatrutide Lyophilized Powder Manufacturer Supply RT10 RT20 RT30 RT40-Detailed Image 4

    Certificates

    Basic Info
    Product Name:

    KLOW80

    CAS No.:

    654724-35-3

    Categories:

    Polypeptide

    Research
    Class:

    Triple agonist — GCGR, GIPR, GLP-1R

    Status:

    Investigational (Phase 3)

    Mechanism:

    Simultaneously activates glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor (GLP-1R). Engineered from the native GIP backbone with amino acid substitutions to confer GCGR and GLP-1R activity.

    EC50 (Human GCGR):

    5.79 nM

    EC50 (Mouse GIPR):

    0.191 nM

    EC50 (Mouse GLP1R):

    0.794 nM

    EC50 (Mouse GCGR):

    2.32 nM

    EC50 (Human GLP1R):

    0.775 nM

    EC50 (Human GIPR):

    0.0643 nM

    Source:

    Jastreboff AM, et al. N Engl J Med. 2023;389(6):514-526.DOI

    Clinical Development:

    NCT04881760; NCT05882045; NCT06354660

    References
    ChEMBL:

    CHEMBL5095485

    DrugBank:

    DB18993

    KEGG DRUG:

    D12430

    PubChem:

    PubChem

    Disclaimer:

    Retatrutide is an investigational compound not yet approved by FDA or EMA. This listing is for industrial and laboratory research use only. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    Peptides,Tirzepatide,Retatrutide,GLP-1,Semaglutide,AMK-CU

    Location:

    18 Linchang, Wujin district, Changzhou, China

    Payment Terms:

    TT against copy of documents,100% TT in advance

    Total Annual Revenue:

    $5 million-$10 million

    Total Employees:

    51-100

    Year of Establishment:

    2026

    Company Profile

    HANGZHOU PLANOVO BIOTECH CO LTD. was officially established on August 25, 2016, at Linchang Group, Mandun Village, Jiaze Town, Wujin District, Changzhou, Jiangsu Province, China. As an innovative enterprise dedicated to the biotechnology sector, the company has quickly made its mark in the industry through outstanding R&D capabilities, rigorous quality control, and a diversified business portfolio, guided by its corporate philosophy of "Quality First, Customer Supreme, Innovation-driven, Integrity in Service."

    Business Scope

    The company's business covers a wide range of areas:

    • Biotechnology and Medical Device R&D Consulting: Focusing on frontier biotechnology research and driving the translation of scientific achievements into practical applications;

    • Cosmetics Production and Sales: Offering high-quality cosmetic products built on a mature R&D and manufacturing system;

    • Medical Device Manufacturing and Sales: Covering Class I, Class II, and Class III medical devices, strictly in accordance with the approved scope of relevant licenses.

    R&D Strength

    The company has an R&D team composed of senior researchers and professional technical talents who uphold the spirit of innovation and focus on R&D and consulting services in biotechnology and medical device technology. The team continuously explores cutting-edge technologies, dedicated to converting the latest scientific research results into practical applications and providing a steady stream of momentum for product innovation.

    Main Product: Tirzepatide/Retatrutide/Semaglutide/CBL-514/Peptide/GLP-1/GHK-CU/NAD+

  • Inquiry History
    4 Inquiries
    Country Product Purchase Quantity Date Posted
    Malaysia

    klow80

    30 MG Jul 23, 2026
    Canada

    KLOW80

    10 PCS Sep 8, 2026
    United States

    KLOW80

    1 MT Aug 10, 2026
    United States

    klow80

    20 MG Jul 27, 2026
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.